Although vitamin D supplementation alone does not seem to influence MS progression and severity in pwMS (36–39), IFNβ and vitamin D combination could remain relevant as vitamin D enhances IFNβ response (40). The gene discussed is IFNB1; the disease is myeloid sarcoma.